Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01591
Species: Homo sapiens
Position : chr2:60722150-60722350
Year: 2020
Title: Therapeutic base editing of human hematopoietic stem cells
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Normal
Disease Name: --
PMID:  32284612
MONDO:
Tissue: Bone Marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: CD34+ hematopoietic stem/progenitor cells
CVCL ID:
Cell Type: hematopoietic stem cell
Cell Ontology ID: CL:0001029
Experiment Type: Enhancer activity assay, Functional perturbation assay, TF binding assay
High Throughput Method: RNA-seq, ChIP-seq
Low Throughput Method: CRISPR Knockout, qRT-PCR, Flow Cytometry
About Target Gene
Target gene : BCL11A
About TF
TF name : GATA1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
GATA1 C-MYB transcription factor network pid 87
GATA1 Factors involved in megakaryocyte development and platelet production reactome 111
GATA1 IL3 netpath 84
GATA1 Notch-mediated HES/HEY network pid 48
GATA1 p73 transcription factor network pid 80
GATA1 Signaling events mediated by HDAC Class I pid 89
GATA1 Signaling events mediated by HDAC Class II pid 58
Enhancer Associated Network
Overlapping Enhancers (hg38) 1 found
Enhancer ID Position Tissue Cell Disease
E_01987 chr2:60722225-60722425 Lung non-small cell lung carcinoma cell non-small cell lung carcinoma
Expression of Target Genes for the Enhancer